TORONTO, Jan. 13, 2020 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services will be kicking off the new year by attending the J.P. Morgan Healthcare and Biotech Showcase Conferences in San Francisco.
“The team is looking forward to a successful week of meetings and events, and the opportunity to learn about the exciting work of so many inspiring life sciences companies. We are anticipating excellent conversations and are always excited to develop new relationships with leading edge organizations,” contributed Andrew Schachter, Axiom’s Founder and CEO.
“The number and caliber of companies convening around the J.P. Morgan week events provides an excellent forum for the development of high potential partnerships and opportunities. We are always excited to start the year off speaking with innovators and leaders,” further contributed Sarah Glofcheskie, Chief Strategy Officer.
“Axiom Real-Time Metrics has a long-standing history of supporting oncology trials in therapeutic areas including Multiple Myeloma, Leukemia, Hodgkin and non-Hodgkin Lymphoma, Ovarian, Fallopian and Peritoneal, Breast, Pancreatic, and Colorectal. Our integrated Fusion eClinical Suite allows for complete study management within one platform facilitating the logistical aspects of complex trials. Fusion’s patient profile allows for instant insight into key subject data and facilitates the monitoring for safety trends,” shared Meredith Frank-Molnia, Senior Director, Clinical Management.